Hip Replacement Problems Reported To FDA On The Rise
Hip replacement problems reported to the Food and Drug Administration (FDA) are on the uptick, reported the New York Times, primarily due to issues with metal-on-metal artificial hips. The paper reported that the FDA received more than 5,000 complaints to date in 2011 alone.
The New York Times reported that their investigation showed that while hip replacement parts may be expected to last about 15 years, many people are experiencing deterioration or complications that otherwise require a new replacement sooner. Among the complaints to the FDA include reports of problems caused by metallic pieces that wear off metal-on-metal the hip replacement parts as they rub against each other during use. In August of 2010, DePuy Orthopaedics, Inc., a division of Johnson & Johnson, Inc., voluntarily recalled its ASR™ XL Acetabular System and DePuy ASR™ Hip Resurfacing System because of complaints about failed hip implants.
The FDA has declared that hip replacement manufacturers begin looking into the issue, according to the New York Times, however collecting that information is a challenge. The FDA’s Dr. William Maisel was quoted by the paper as saying, “There is not an existing infrastructure for studying this kind of information.”